223 related articles for article (PubMed ID: 34159471)
21. Expression of SRY-related HMG Box Transcription Factors (Sox) 2 and 9 in Craniopharyngioma Subtypes and Surrounding Brain Tissue.
Thimsen V; John N; Buchfelder M; Flitsch J; Fahlbusch R; Stefanits H; Knosp E; Losa M; Buslei R; Hölsken A
Sci Rep; 2017 Nov; 7(1):15856. PubMed ID: 29158570
[TBL] [Abstract][Full Text] [Related]
22. Adult Craniopharyngioma: Case Series, Systematic Review, and Meta-Analysis.
Dandurand C; Sepehry AA; Asadi Lari MH; Akagami R; Gooderham P
Neurosurgery; 2018 Oct; 83(4):631-641. PubMed ID: 29267973
[TBL] [Abstract][Full Text] [Related]
23. Subtype-dependent difference of glucose transporter 1 and hexokinase II expression in craniopharyngioma: an immunohistochemical study.
Mukada N; Tosaka M; Matsumura N; Yamaguchi R; Aihara M; Isoda K; Higuchi T; Tsushima Y; Yokoo H; Yoshimoto Y
Sci Rep; 2021 Jan; 11(1):126. PubMed ID: 33420213
[TBL] [Abstract][Full Text] [Related]
24. Papillary craniopharyngioma in a patient following resection of nonfunctioning pituitary adenoma: illustrative case.
Park DJ; Mishra A; Golub D; Li JY; Black KS; Schulder M
J Neurosurg Case Lessons; 2021 Jan; 1(2):CASE2063. PubMed ID: 35854932
[TBL] [Abstract][Full Text] [Related]
25. Endocrine and Visual Outcomes Following Gross Total Resection and Subtotal Resection of Adult Craniopharyngioma: Systematic Review and Meta-Analysis.
Akinduro OO; Izzo A; Lu VM; Ricciardi L; Trifiletti D; Peterson JL; Bernet V; Donaldson A; Eggenberger E; Olomu O; Reimer R; Wharen R; Quinones-Hinojosa A; Chaichana KL
World Neurosurg; 2019 Jul; 127():e656-e668. PubMed ID: 30947004
[TBL] [Abstract][Full Text] [Related]
26. Molecular pathology of adamantinomatous craniopharyngioma: review and opportunities for practice.
Apps JR; Martinez-Barbera JP
Neurosurg Focus; 2016 Dec; 41(6):E4. PubMed ID: 27903120
[TBL] [Abstract][Full Text] [Related]
27. Growth patterns of craniopharyngiomas: clinical analysis of 226 patients.
Pan J; Qi S; Liu Y; Lu Y; Peng J; Zhang X; Xu Y; Huang GL; Fan J
J Neurosurg Pediatr; 2016 Apr; 17(4):418-33. PubMed ID: 26636252
[TBL] [Abstract][Full Text] [Related]
28. Interleukin‑6 induces an epithelial‑mesenchymal transition phenotype in human adamantinomatous craniopharyngioma cells and promotes tumor cell migration.
Zhou J; Zhang C; Pan J; Chen L; Qi ST
Mol Med Rep; 2017 Jun; 15(6):4123-4131. PubMed ID: 28487953
[TBL] [Abstract][Full Text] [Related]
29. Predictive factors for craniopharyngioma recurrence: a systematic review and illustrative case report of a rapid recurrence.
Prieto R; Pascual JM; Subhi-Issa I; Jorquera M; Yus M; Martínez R
World Neurosurg; 2013; 79(5-6):733-49. PubMed ID: 22892136
[TBL] [Abstract][Full Text] [Related]
30. Risk Factors Associated with Postoperative Obesity in Childhood-Onset Craniopharyngioma Patients: A Case-Control Study.
Huang Z; Wu J; Qi J; Pan C; Fu J; Hong T
World Neurosurg; 2022 Nov; 167():e1185-e1195. PubMed ID: 36096392
[TBL] [Abstract][Full Text] [Related]
31. Papillary craniopharyngioma: A clinicopathologic study of a rare entity from a major tertiary care center in Pakistan.
Tariq MU; Din NU; Ahmad Z; Memon W
Neurol India; 2017; 65(3):570-576. PubMed ID: 28488624
[TBL] [Abstract][Full Text] [Related]
32. Craniopharyngioma: a roadmap for scientific translation.
Gupta S; Bi WL; Giantini Larsen A; Al-Abdulmohsen S; Abedalthagafi M; Dunn IF
Neurosurg Focus; 2018 Jun; 44(6):E12. PubMed ID: 29852761
[TBL] [Abstract][Full Text] [Related]
33. Papillary craniopharyngioma: a clinicopathological study of 48 cases.
Crotty TB; Scheithauer BW; Young WF; Davis DH; Shaw EG; Miller GM; Burger PC
J Neurosurg; 1995 Aug; 83(2):206-14. PubMed ID: 7616262
[TBL] [Abstract][Full Text] [Related]
34. Differential Expression of Stem Cell Markers in Human Adamantinomatous Craniopharyngioma and Pituitary Adenoma.
Chang CV; Araujo RV; Cirqueira CS; Cani CM; Matushita H; Cescato VA; Fragoso MC; Bronstein MD; Zerbini MC; Mendonca BB; Carvalho LR
Neuroendocrinology; 2017; 104(2):183-193. PubMed ID: 27161333
[TBL] [Abstract][Full Text] [Related]
35. Identification and Functional Enrichment Analysis of Potential Diagnostic and Therapeutic Targets in Adamantinomatous Craniopharyngioma.
Zou YF; Meng LB; Wang QQ; He ZK; Hu CH; Shan MJ; Wang DY; Yu X
J Comput Biol; 2020 Jan; 27(1):55-68. PubMed ID: 31424286
[TBL] [Abstract][Full Text] [Related]
36. Do craniopharyngioma molecular signatures correlate with clinical characteristics?
Omay SB; Chen YN; Almeida JP; Ruiz-Treviño AS; Boockvar JA; Stieg PE; Greenfield JP; Souweidane MM; Kacker A; Pisapia DJ; Anand VK; Schwartz TH
J Neurosurg; 2018 May; 128(5):1473-1478. PubMed ID: 28707994
[TBL] [Abstract][Full Text] [Related]
37. Analysis and Long-Term Follow-Up of the Surgical Treatment of Children With Craniopharyngioma.
Cheng J; Shao Q; Pan Z; You J
J Craniofac Surg; 2016 Nov; 27(8):e763-e766. PubMed ID: 28005815
[TBL] [Abstract][Full Text] [Related]
38. Risk factors associated with the surgical management of craniopharyngiomas in pediatric patients: analysis of 1961 patients from a national registry database.
Bakhsheshian J; Jin DL; Chang KE; Strickland BA; Donoho DA; Cen S; Mack WJ; Attenello F; Christian EA; Zada G
Neurosurg Focus; 2016 Dec; 41(6):E8. PubMed ID: 27903117
[TBL] [Abstract][Full Text] [Related]
39. Targeted therapies in the medical management of craniopharyngioma.
Iglesias P
Pituitary; 2022 Jun; 25(3):383-392. PubMed ID: 35301645
[TBL] [Abstract][Full Text] [Related]
40. Collision of Craniopharyngioma and Pituitary Adenoma: Comprehensive Review of an Extremely Rare Sellar Condition.
Hasegawa H; Jentoft ME; Young WF; Lakomkin N; Van Gompel JJ; Link MJ; Atkinson JL; Meyer FB
World Neurosurg; 2021 May; 149():e51-e62. PubMed ID: 33647491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
